Functional genomics of osteoarthritis - On the way to evaluate disease hypotheses

被引:26
作者
Aigner, T
Bartnik, E
Sohler, F
Zimmer, R
机构
[1] Univ Erlangen Nurnberg, Dept Pathol, Osteoart & Arthrit Res, D-91054 Erlangen, Germany
[2] Aventis Pharma Deutschland, Dis Grp Osteoarthrit, Frankfurt, Germany
[3] Univ Munich, Dept Comp Sci, Munich, Germany
关键词
D O I
10.1097/01.blo.0000143838.53434.b8
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Functional genomics is a challenging new way to address complex diseases such as osteoarthritis on a molecular level. This complements previous research and will open up new areas of so far unrecognized molecular networks. In this respect, articular cartilage is a good target for functional genomics as it contains only one cell type to which all expression signals can be attributed to. Despite considerable limitations at present, such as a low sensitivity and insensitivity to alternative splicing, posttranscriptional regulation, and posttranslational modification, cDNA-array technology provides a powerful tool to obtain an overview on gene expression patterns hardly achievable with other techniques. This has been shown to be true for known genes as well as for the identification of new genes of interest. Therefore, gene expression analysis will help to identify single genes depending on the disease and experimental conditions investigated. However, the expression pattern of the plethora of expressed genes will paint a picture (network) of disease context, maybe even more pushing forward our understanding of complex diseases such as osteoarthritis.
引用
收藏
页码:S138 / S143
页数:6
相关论文
共 24 条
[1]  
Aigner T, 1999, ARTHRITIS RHEUM, V42, P1443, DOI 10.1002/1529-0131(199907)42:7<1443::AID-ANR18>3.0.CO
[2]  
2-A
[3]   ACTIVATION OF COLLAGEN TYPE-II EXPRESSION IN OSTEOARTHRITIC AND RHEUMATOID CARTILAGE [J].
AIGNER, T ;
STOSS, H ;
WESELOH, G ;
ZEILER, G ;
VONDERMARK, K .
VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1992, 62 (06) :337-345
[4]  
Aigner T, 2001, ARTHRITIS RHEUM-US, V44, P2777, DOI 10.1002/1529-0131(200112)44:12<2777::AID-ART465>3.0.CO
[5]  
2-H
[6]   Functional genomics of osteoarthritis [J].
Aigner, T ;
Bartnik, E ;
Zien, A ;
Zimmer, R .
PHARMACOGENOMICS, 2002, 3 (05) :635-650
[7]   Functional genomic analysis of type-II IL-1β decoy receptor:: Potential for gene therapy in human arthritis and inflammation [J].
Attur, MG ;
Dave, MN ;
Leung, MY ;
Cipolletta, C ;
Meseck, M ;
Woo, SLC ;
Amin, AR .
JOURNAL OF IMMUNOLOGY, 2002, 168 (04) :2001-2010
[8]   Molecular phenotyping of human chondrocyte cell lines T/C-28a2, T/C-28a4, and C-28/I2 [J].
Finger, F ;
Schörle, C ;
Zien, A ;
Gebhard, P ;
Goldring, MB ;
Aigner, T .
ARTHRITIS AND RHEUMATISM, 2003, 48 (12) :3395-3403
[9]  
FUCHTBAUER EM, 1995, DEV DYNAM, V204, P316
[10]   Quantification of expression levels of cellular differentiation markers does not support a general shift in the cellular phenotype of osteoarthritic chondrocytes [J].
Gebhard, PM ;
Gehrsitz, A ;
Bau, B ;
Söder, S ;
Eger, W ;
Aigner, T .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2003, 21 (01) :96-101